COMP <GO>
CPAY vs FISV // REVENUE GROWTH (YOY)
Corpay Inc. (NYSE) VS. Fiserv Inc. (NASDAQ) • 15-METRIC TALLY: CPAY 6
— FISV 6
▲ REVENUE GROWTH (YOY) LEADER: CPAY
LAST: $397.97 (+0.53%) • MKT CAP: $26.13B
revenue-growth
13.90%
LAST: $48.48 (+1.30%) • MKT CAP: $25.78B
revenue-growth
3.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CPAY VS. FISV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CPAY | FISV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.20% | 9.60% | +13.60 | CPAY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.4x | 6.5x | +6.90 | FISV | /valuation <GO> |
| Free Cash Flow Yield | 4.97% | 16.68% | -11.71 | FISV | /fcf-yield <GO> |
| Operating Margin | 44.00% | 27.50% | +16.50 | CPAY | /operating-margins <GO> |
| Net Profit Margin | 23.60% | 16.40% | +7.20 | CPAY | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 13.90% | 3.60% | +10.30 | CPAY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.19 | 1.27 | +0.92 | CPAY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | FISV | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.2 | 51.9 | -4.70 | FISV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.16 | -0.05 | FISV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 20.5x | 6.9x | +13.60 | FISV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $26.13B | $25.78B | $350.5M | CPAY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CPAY REV | FISV REV | CPAY GROSS % | FISV GROSS % | CPAY FCF | FISV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.53B | $21.19B | — | — | $1.30B | $4.30B |
| FY 2024 | $3.97B | $20.46B | — | — | $1.77B | $5.06B |
| FY 2023 | $3.76B | $19.09B | — | — | $1.93B | $4.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CPAY // BETA 1.11
FISV // BETA 1.16